Biofrontera Inc. (BFRI) stock
BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$0.59+0.02 (+4.09%)
Close on Nov 17, 2026Market cap $8.81MP/E –Yield –
Biofrontera market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Biofrontera's market cap was $13.32M on Nov 11, 2026, against $9.52M a year earlier. Over the last 5 years it ranged from $1.27M to $63.29M, with a median of $11.15M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.32M | +100.6% |
| 2025 | Dec 31, 2025 | $6.64M | -6.7% |
| 2024 | Dec 31, 2024 | $7.12M | +87.9% |
| 2023 | Dec 29, 2023 | $3.79M | -82.5% |
| 2022 | Dec 30, 2022 | $21.59M | -64.1% |
| 2021 | Dec 31, 2021 | $60.16M | – |
See a number that looks wrong?